Filing Analysis
SenesTech, Inc. filed an 8-K to announce its financial results for the second quarter ended June 30, 2026. The filing serves as a formal notice that earnings data has been released via press release.
📋 Key Facts
- Report date: August 5, 2026
- Reporting period: Second Quarter ended June 30, 2026
- The filing includes the announcement of financial results and other information in Exhibit 99.1.
- Signed by Thomas C. Chesterman, CFO.
SenesTech, Inc. issued an 8-K to announce the results of its second quarter 2026 operations, specifically highlighting growth in its e-commerce business segment.
📋 Key Facts
- Report date: August 3, 2026
- The filing discusses Q2 2026 operational performance via a press release (Exhibit 99.1).
- Focus of the announcement is the growth of the company's e-commerce business.
SenesTech, Inc. reported the results of its 2026 annual meeting of stockholders held on June 9, 2026. The meeting resulted in the election of Class I directors, approval of executive compensation, an increase in the 2018 Equity Incentive Plan, and the ratification of its independent auditor.
📋 Key Facts
- Election of Jake S. Leach and Joshua M. Moss as Class I directors for three-year terms ending in 2029.
- Approval of the 2018 Equity Incentive Plan amendment to increase available common stock by 1,200,000 shares.
- Non-binding advisory approval of fiscal 2025 executive compensation ('Say-on-Pay').
- Ratification of M&K CPAS, PLLC as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
SenesTech, Inc. announced its financial results for the first quarter ended March 31, 2026. The disclosure was made via a press release furnished as an exhibit to the 8-K filing.
📋 Key Facts
- The filing reports financial results for the fiscal quarter ended March 31, 2026.
- The announcement was made on May 12, 2026.
- The report was filed under Item 2.02 (Results of Operations and Financial Condition).
- A press release containing the results was included as Exhibit 99.1.
SenesTech, Inc. has appointed Michael Edell as President and CEO, effective May 6, 2026, succeeding Joel L. Fruendt. Edell, who previously served as the company's Interim COO, was also appointed to the Board of Directors.
🚩 Red Flags
- High potential dilution: The 5% equity grant to the new CEO is significant for a micro-cap company.
- Equity plan exhaustion: The company currently lacks sufficient shares in its incentive plan to cover the CEO's grant, requiring a future stockholder vote.
📋 Key Facts
- Michael Edell appointed as President and CEO on May 6, 2026, succeeding Joel L. Fruendt.
- Edell previously served as the Company's Interim COO from October 2025 to May 2026.
- The new CEO's compensation includes a $360,000 base salary and a target annual bonus of 60% of base salary.
- Edell was granted an option to purchase 5.0% of the Company's outstanding common stock, vesting over three years.
- The equity grant is contingent upon stockholders approving an increase in the number of shares reserved under the 2018 Equity Incentive Plan.
- Jamie Bechtel's role as Interim Executive Chair concluded following Edell's appointment.
SenesTech, Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2025. The information was furnished via a press release attached as Exhibit 99.1.
📋 Key Facts
- The report was filed on March 12, 2026, to announce financial results for the period ended December 31, 2025.
- The company utilized Item 2.02 (Results of Operations and Financial Condition) to furnish the earnings data.
- The filing was signed by Thomas C. Chesterman, Executive Vice President and Chief Financial Officer.
SenesTech, Inc. announced the retirement of its President and CEO, Joel L. Fruendt, effective either June 30, 2026, or upon the appointment of a successor. The company has appointed Jamie Bechtel as Interim Executive Chair to oversee the transition.
🚩 Red Flags
- Leadership transition in a micro-cap company can create operational uncertainty during the search for a permanent CEO.
- Significant cash outflow required for severance (salary through year-end 2026) and accelerated equity vesting.
📋 Key Facts
- CEO Joel L. Fruendt notified the company of his retirement on January 22, 2026.
- Retirement effective date is June 30, 2026, or upon appointment of a successor.
- Separation agreement includes base salary continuation through December 15, 2026, and health insurance coverage until December 31, 2026.
- Stock options for the departing CEO will undergo accelerated vesting subject to a release of claims.
- Jamie Bechtel appointed as Interim Executive Chair on January 26, 2026, with an annual compensation of $247,500.
SenesTech, Inc. announced the retirement of its President and CEO, Joel L. Fruendt, effective either June 30, 2026, or upon the appointment of a successor. The company has appointed Jamie Bechtel as Interim Executive Chair to oversee leadership during this transition.
🚩 Red Flags
- Leadership transition in a micro-cap company can create operational uncertainty.
- Significant severance obligations including salary continuation and accelerated option vesting.
📋 Key Facts
- CEO Joel L. Fruendt will retire effective June 30, 2026, or when a successor is named.
- Fruendt's separation agreement includes base salary continuation through December 15, 2026, and health insurance coverage until year-end 2026.
- The agreement includes the acceleration of vesting for Mr. Fruendt's stock options.
- Jamie Bechtel appointed as Interim Executive Chair on January 26, 2026.
- Interim Executive Chair compensation is set at $247,500 per year.
SenesTech, Inc. announced the employment agreement for Michael Edell to serve as Interim Chief Operating Officer, effective November 3, 2025.
🚩 Red Flags
- Interim status of a key executive officer may indicate ongoing management instability or transition.
📋 Key Facts
- Michael Edell appointed as Interim Chief Operating Officer (COO) effective November 3, 2025.
- Monthly salary of $30,000.
- Potential bonuses: up to $25,000 for Q4 2025 and up to $30,000 for Q1 2026.
- The role is at-will with a 60-day notice period required by the company for termination without cause.
- No company-sponsored benefits (health insurance, retirement, etc.) are provided due to the interim nature of the role.
- Employment term is expected to last approximately six months.
SenesTech, Inc. announced its financial results for the third quarter ended September 30, 2025. The filing serves as a formal announcement of quarterly earnings via an attached press release.
📋 Key Facts
- Reporting period: Third Quarter ended September 30, 2025.
- Announcement date: November 10, 2025.
- The financial results were furnished pursuant to Item 2.02 and are not considered 'filed' for purposes of Section 18 liability.
SenesTech, Inc. has appointed Michael Edell as Interim Chief Operating Officer effective October 15, 2025. The appointment is for an interim term with a monthly compensation of $30,000 and no standard benefits or severance.
🚩 Red Flags
- The use of an 'Interim' officer often suggests internal restructuring or sudden vacancy in the C-suite.
📋 Key Facts
- Michael Edell appointed as Interim COO on October 15, 2025.
- Interim compensation set at $30,000 per month.
- No eligibility for standard benefits (health insurance, retirement, PTO) due to interim status.
- No entitlement to severance or post-termination compensation.
- Edell has a background in consumer package goods and entrepreneurship (Westlake Serial Company, LLC; MaddieBrit Products, LLC).
SenesTech, Inc. filed a prospectus supplement to register an additional $7,580,675 of common stock under its existing At-The-Market (ATM) offering agreement with H.C. Wainwright & Co., LLC.
🚩 Red Flags
- Dilutive potential: The registration of over $7.5M in new common stock via an ATM program typically results in significant dilution for existing shareholders.
📋 Key Facts
- Registration of additional $7,580,675 in common stock via prospectus supplement.
- Offering is pursuant to an ATM Offering Agreement dated June 20, 2024, with H.C. Wainwright & Co., LLC.
- The company has previously sold approximately $3,048,894.72 through this same Sales Agreement.
- Legal opinion regarding the legality of the shares was filed as Exhibit 5.1.
SenesTech, Inc. announced its financial results for the second quarter ended June 30, 2025. The filing serves as a formal announcement of quarterly earnings via an attached press release.
📋 Key Facts
- Reporting period: Second Quarter ended June 30, 2025.
- Announcement date: August 7, 2025.
- The financial results were furnished pursuant to Item 2.02 of Form 8-K.
SenesTech entered into inducement agreements to encourage existing warrant holders to exercise warrants for cash. In exchange, the company is issuing new short-term warrants and providing a $0.125 per share premium to induce immediate liquidity.
🚩 Red Flags
- Inducement/Sweetener: The company is paying a premium ($0.125 per share) to existing warrant holders to exercise, suggesting urgent need for cash.
- Significant Dilution: Issuance of over 2 million new warrants at $5.25 represents significant potential dilution for existing shareholders.
- Restrictive Covenants: The one-year ban on Variable Rate Transactions and the 45-day freeze on issuing stock/registration statements limits management's future financing flexibility.
📋 Key Facts
- Existing Warrants: 1,458,872 shares at $4.15 exercise price + $0.125/share inducement fee.
- New Warrants: Up to 2,188,308 new warrant shares issued at an exercise price of $5.25 per share.
- Gross Proceeds: Expected aggregate gross proceeds of approximately $6,327,857.30.
- Placement Agent: H.C. Wainwright & Co., LLC; receiving 7.5% cash fee and 1.0% management fee.
- Placement Agent Warrants: 72,944 shares at an exercise price of $5.4219 per share (125% of offering price).
- Restrictive Covenants: Company agreed not to issue common stock or file new registration statements for 45 days post-closing and no Variable Rate Transactions for one year.
SenesTech, Inc. announced the expansion of its Board of Directors to seven members with the appointment of Lynn Y. Graham as an independent director.
📋 Key Facts
- Board size increased from six to seven members.
- Lynn Y. Graham appointed as an independent director (Class III).
- Ms. Graham will serve until the 2028 Annual Meeting or until resignation/removal.
- Ms. Graham appointed to the Commercialization Committee.
SenesTech entered into inducement agreements to encourage existing warrant holders to exercise warrants for cash. In exchange, the company is issuing new short-term warrants at a higher strike price of $4.15 per share.
🚩 Red Flags
- Inducement of warrant holders often indicates a need for immediate liquidity/cash runway.
- Issuance of new warrants (potential dilution) to facilitate the exercise of old ones.
- The use of 'inducement letters' is frequently seen in companies facing capital constraints.
📋 Key Facts
- Existing warrants (issued March 11, 2025) will be exercised at $2.90/share plus a $0.125/share fee.
- Total expected gross proceeds: $4,413,087.80.
- New Warrants issued to holders have an exercise price of $4.15 per share.
- H.C. Wainwright & Co., LLC acting as exclusive placement agent with a 7.5% cash fee and 1.0% management fee.
- Placement Agent Warrants issued to H.C. Wainwright at an exercise price of $3.7813 per share (125% of the offering price).
- The company agreed not to issue common stock or file new registration statements for 45 days post-closing, and no Variable Rate Transactions for one year.
SenesTech, Inc. has filed a prospectus supplement to register an additional $711,227 of common stock under its existing At-The-Market (ATM) offering agreement with H.C. Wainwright & Co., LLC.
🚩 Red Flags
- Continuous dilution: The company is actively using an ATM offering to raise capital, which typically indicates a need for immediate liquidity and results in ongoing shareholder dilution.
📋 Key Facts
- Registration of additional $711,227 in common stock via Prospectus Supplement.
- Offering is pursuant to an ATM Agreement dated June 20, 2024, with H.C. Wainwright & Co., LLC.
- Aggregate shares already sold under this agreement total $2,854,827.84 prior to this filing.
- Legal opinion regarding the legality of the shares was filed as Exhibit 5.1.
SenesTech, Inc. held its Annual Meeting on June 9, 2025, where stockholders approved a proposal for a reverse stock split (ratio between 1-for-2 and 1-for-12) to maintain Nasdaq listing compliance. The meeting also saw the rejection of an amendment to increase share availability under the 2018 Plan.
🚩 Red Flags
- Approval of a reverse stock split ratio between 1-for-2 and 1-for-12 indicates imminent risk of Nasdaq delisting due to low share price.
- Rejection of the 2018 Plan Amendment (increasing shares by 900,000) suggests shareholder skepticism regarding dilution or capital structure management.
📋 Key Facts
- Annual Meeting held on June 9, 2025.
- Stockholders approved a reverse stock split proposal with a ratio between 1-for-2 and 1-for-12 to comply with Nasdaq Listing Rule 5635(d).
- Joel L. Fruendt and Matthew K. Szot were elected as Class III directors for three-year terms ending in 2028.
- M&K CPAS, PLLC was ratified as the independent registered public accounting firm for fiscal year 2025.
- The 'Say-on-Pay' advisory vote for executive compensation was approved (172,517 For vs. 87,093 Against).
- Stockholders rejected the amendment to increase shares available under the 2018 Plan by 900,000 shares.
- The 'Issuance Proposal' regarding warrant issuances was approved (161,168 For vs. 79,178 Against).
- An adjournment proposal was approved to allow for further proxy solicitation if needed.
SenesTech, Inc. announced its financial results for the first quarter ended March 31, 2025. The filing serves as a formal announcement of quarterly earnings via an attached press release.
📋 Key Facts
- Reporting period: First Quarter ended March 31, 2025.
- Announcement date: May 8, 2025.
- The financial results were furnished under Item 2.02 and are not considered 'filed' for purposes of Section 18 liability.
SenesTech, Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2024. The filing serves as a formal announcement of earnings via an attached press release.
📋 Key Facts
- Financial results for Q4 and FY 2024 were released on March 12, 2025.
- The reporting period ended on December 31, 2024.
- Results are furnished under Item 2.02 of Form 8-K.
SenesTech entered into inducement agreements to encourage existing warrant holders to exercise warrants at a significantly reduced price of $2.90 per share (down from $4.35). In exchange, the company is issuing a massive amount of new warrants totaling approximately 1.5 million shares, which will lead to substantial dilution upon exercise.
🚩 Red Flags
- Significant Dilution: The issuance of nearly 1.5 million new warrants at a low exercise price represents massive potential dilution for existing shareholders.
- Down-round/Discounted Exercise: Reducing the exercise price from $4.35 to $2.90 is a clear signal of liquidity distress or an attempt to prevent warrant expiration without cash inflow.
- Warrant Overhang: The scale of new warrants relative to the small amount of cash raised ($1.08M) creates significant future selling pressure.
📋 Key Facts
- Existing Warrants: 374,718 shares at an original price of $4.35/share being reduced to $2.90/share.
- New Warrants: Issuance of up to 1,498,872 new common stock purchase warrants at an exercise price of $2.90 per share.
- Expected Gross Proceeds: $1,086,682.20 from the exercise of existing warrants.
- Placement Agent Fees: 7.5% cash fee and 1.0% management fee on gross proceeds, plus warrants for H.C. Wainwright & Co., LLC.
- Closing Date: Expected on or about March 11, 2025.
- Use of Proceeds: Working capital and general corporate purposes.
SenesTech, Inc. announced the appointment of Joshua M. Moss to its Board of Directors as an independent director. Mr. Moss will also serve on the Audit and Commercialization Committees.
📋 Key Facts
- Board size increased from five to six members.
- Joshua M. Moss appointed as a Class I independent director effective January 8, 2025.
- Mr. Moss appointed to the Audit Committee and the Commercialization Committee.
- Compensation for Mr. Moss will follow the terms outlined in the company's May 28, 2024 Proxy Statement.
SenesTech, Inc. announced its financial results for the third quarter ended September 30, 2024. The filing serves as a formal announcement of quarterly earnings via an attached press release.
📋 Key Facts
- Reporting period: Third Quarter ended September 30, 2024.
- Announcement date: November 12, 2024.
- The financial results were furnished pursuant to Item 2.02 and are not considered 'filed' for liability purposes under Section 18 of the Exchange Act.
SenesTech entered into an inducement letter to facilitate the exercise of existing warrants at a significantly reduced price ($4.60 vs. previous prices up to $86.42) in exchange for issuing new warrants with a low strike price of $4.35. This transaction is designed to raise approximately $2.3 million in gross proceeds for working capital.
🚩 Red Flags
- Significant dilution: The issuance of over 1 million new warrant shares at a low strike price ($4.35) will result in substantial dilution for existing shareholders.
- Extreme warrant price reduction: Existing warrants previously priced as high as $86.42 are being allowed to exercise at $4.60, indicating significant distress or a need for immediate liquidity.
- Death spiral potential: The low-priced new warrants and the use of 'cashless exercise' provisions can lead to rapid dilution if the stock price fluctuates.
📋 Key Facts
- Entered into an Inducement Letter on August 22, 2024.
- Existing warrants (August 2023 and November 2023) will be exercised at a reduced price of $4.60 per share.
- New Warrants issued to holders with an exercise price of $4.35 per share for up to 1,011,004 shares.
- Expected aggregate gross proceeds from warrant exercises: $2,325,306.20.
- H.C. Wainwright & Co., LLC engaged as exclusive placement agent with a 7.5% cash fee and 1.0% management fee.
- Placement Agent to receive warrants for up to 25,275 shares at an exercise price of $5.75 (125% of offering price).
- Company agreed not to issue common stock or file new registration statements for 60 days post-closing.
SenesTech, Inc. announced its financial results for the second quarter ended June 30, 2024. The filing serves as a formal announcement of the earnings release via press release.
📋 Key Facts
- Reporting period: Second Quarter ended June 30, 2024.
- Announcement date: August 8, 2024.
- The financial results were furnished pursuant to Item 2.02 of Form 8-K.
SenesTech received a notification from Nasdaq stating the company is non-compliant with Audit Committee requirements following the departure of Board member Delphine François Chiavarini. The company has been granted a cure period to appoint an independent director to regain compliance and avoid delisting.
🚩 Red Flags
- Delisting notice/Non-compliance with Nasdaq Listing Rule 5605
- Loss of Audit Committee independence due to board member departure
📋 Key Facts
- Delphine François Chiavarini's board term expired at the 2024 annual meeting; she also served on the Audit Committee.
- Departure effective date: July 11, 2024.
- Nasdaq Rule 5605 requires an Audit Committee comprised of at least three independent directors.
- Cure period expires either at the next annual stockholders' meeting (if before Jan 7, 2025) or by July 11, 2025.
- The company is actively seeking a qualified independent director to resolve the deficiency.
SenesTech, Inc. has implemented a 1-for-10 reverse stock split effective July 24, 2024, following stockholder approval on July 11, 2024. This action was taken to amend the company's Certificate of Incorporation and change its CUSIP number.
🚩 Red Flags
- Reverse stock split implementation is a common signal of attempting to maintain Nasdaq compliance regarding minimum bid price requirements.
📋 Key Facts
- Reverse stock split ratio: 1-for-10 (1:10).
- Effective time: 4:01 p.m. ET on July 24, 2024.
- Stockholders approved the proposal at the Annual Meeting on July 11, 2024.
- New CUSIP number for Common Stock: 81720R 604.
- Fractional shares will be rounded up to the nearest whole share (for direct holders) or rounded down (for equity incentive plan awards).
SenesTech, Inc. held its annual meeting of stockholders on July 11, 2024, where shareholders approved several key items, most notably a proposal for a reverse stock split ranging from 1-for-2 to 1-for-20.
🚩 Red Flags
- Approval of a reverse stock split (1-for-2 to 1-for-20) often indicates a need to boost share price to maintain Nasdaq compliance.
- The approval of an adjournment proposal suggests there may have been insufficient votes initially to pass the critical reverse split.
📋 Key Facts
- Annual Meeting held on July 11, 2024, in Phoenix, AZ.
- Stockholders approved an amendment to the 2018 Equity Incentive Plan to increase available shares by 2,000,000.
- Stockholders approved a reverse stock split proposal with a ratio between 1-for-2 and 1-for-20, to be determined by the Board.
- M&K CPAS, PLLC was ratified as the independent registered public accounting firm for fiscal year ending Dec 31, 2024.
- Jamie Bechtel and Phil Grandinetti III were elected as Class II directors.
- Say-on-pay proposal received majority support (669,439 votes in favor).
- Adjournment of the meeting was approved to allow for further proxy solicitation if needed for the reverse split.
SenesTech, Inc. entered into an At-The-Market (ATM) offering agreement with H.C. Wainwright & Co., LLC to sell common stock for aggregate gross proceeds of up to $1,575,944.
🚩 Red Flags
- ATM offerings are often used by micro-cap companies to raise immediate working capital, which can lead to significant shareholder dilution.
- The relatively small maximum amount ($1.57M) suggests the company may be seeking incremental liquidity to fund near-term operations.
📋 Key Facts
- Agreement date: June 20, 2024
- Sales Agent: H.C. Wainwright & Co., LLC
- Maximum aggregate gross proceeds: $1,575,944
- Placement fee: 3.0% of the gross sales price (unless Wainwright acts as principal)
- The offering is conducted via a previously filed shelf registration statement on Form S-3 (No. 333-261227) effective May 6, 2022.
SenesTech, Inc. announced its financial results for the first quarter ended March 31, 2024 via an 8-K filing on May 9, 2024.
📋 Key Facts
- Reporting period: First Quarter ended March 31, 2024
- Filing date: May 9, 2024
- The company furnished financial results via press release (Exhibit 99.1) under Item 2.02.
SenesTech, Inc. has announced the date for its 2024 Annual Meeting of Stockholders, scheduled for July 11, 2024. Due to a scheduling shift from the previous year, the company is providing revised deadlines for stockholder proposals and director nominations.
📋 Key Facts
- The 2024 Annual Meeting of Stockholders is scheduled for July 11, 2024.
- Stockholders of record as of the close of business on May 24, 2024, will be entitled to vote.
- The deadline for stockholder proposals or director nominations to be included in proxy materials is the close of business on May 6, 2024.
- Proposals must be submitted in writing to the Company Secretary, Thomas C. Chesterman.
SenesTech received a 180-day extension from Nasdaq to regain compliance with the minimum bid price requirement. The company must maintain a $1.00 closing bid price for at least 10 consecutive business days by August 19, 2024, or face delisting.
🚩 Red Flags
- Failure to regain compliance during the initial 180-day window
- Explicit mention of an intended reverse stock split to avoid delisting
- Risk of delisting from Nasdaq remains high if price does not recover by August 2024
📋 Key Facts
- The company failed to meet the Nasdaq Rule 5550(a)(2) minimum bid price requirement ($1.00/share) during the initial 180-day period ending February 21, 2024.
- Nasdaq granted a second 180-day compliance period extending until August 19, 2024.
- Compliance requires the stock to close at $1.00 or higher for 10 consecutive business days.
- The company has notified Nasdaq of its intent to cure the deficiency via a reverse stock split if necessary.
SenesTech, Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2023.
📋 Key Facts
- Report date: February 21, 2024
- Reporting period: Fourth quarter and fiscal year ended December 31, 2023
- The filing is an announcement of financial results via press release (Exhibit 99.1)